Promising results of HIV prevention trials highlight the benefits of collaboration in global health: The perspective of the Forum HIV Recency Assay Working Group

This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [INV045445]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. The Forum for Collaborative Research, as an organization, also receives grants from the pharmaceutical industry but these are unrestricted and not specific to the work described in this article. Additional support was provided by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The sponsors of this work contributed to the discussions in the working group meetings that led to this article’s development; however, the sponsors had no role in writing the article and deciding to submit the paper for publication. The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated.

Authors

Institutions

Publication Details

Journal
PLOS Global Public Health
Published
2024-10-24
DOI
https://doi.org/10.1371/journal.pgph.0003878
Citations
2
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
0.78

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Promising results of HIV prevention trials highlight the benefits of collaboration in global health: The perspective of the Forum HIV Recency Assay Working Group

Shona Dalal, Oliver Laeyendecker, Diana Zeballos, Brian Rice et al.
2 citations
PLOS Global Public Health
HIV/AIDS Research and Interventions
0.78
article

Promising results of HIV prevention trials highlight the benefits of collaboration in global health: The perspective of the Forum HIV Recency Assay Working Group

Shona Dalal, Oliver Laeyendecker, Diana Zeballos, Brian Rice, Beatriz Gilda Jegerhorn Grinsztejn, Kenneth Hugh Mayer, Fei Gao, Grace Kumwenda, Benjamin Chimukangara, Mitchell Warren, Suzue Saito, Veronica Miller, Jeffrey S. Murray, Bharat Parekh, Jessica Justman, Robin Schaefer, Ann Duerr, Frank Maldarelli, Vani Vannappagari, Mitchell Leus, Ha Youn Lee, M Robertson, David V. Glidden, L.J. Donaldson, Jörg Zinserling, Chukwunomso E Osakwe
article en
2 citations

Abstract

This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [INV045445]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. The Forum for Collaborative Research, as an organization, also receives grants from the pharmaceutical industry but these are unrestricted and not specific to the work described in this article. Additional support was provided by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The sponsors of this work contributed to the discussions in the working group meetings that led to this article’s development; however, the sponsors had no role in writing the article and deciding to submit the paper for publication. The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated.

PLOS Global Public HealthVol. 4(10)
University of Southern California (US), Federal Institute for Drugs and Medical Devices (DE), Universidade Federal da Bahia (BR), Centers for Disease Control and Prevention (US), National Institutes of Health (US), Beth Israel Deaconess Medical Center (US), University of California, San Francisco (US), Malawi University of Science and Technology (MW), Beebe Healthcare (US), Fred Hutch Cancer Center (US), World Health Organization (CH), Instituto de Saúde (BR), National Institute of Allergy and Infectious Diseases (US), Statistics Collaborative (US), National Cancer Institute (US), Nipomo Health Center (US), ICAP Global Health, Fenway Health (US), Fundação Oswaldo Cruz (BR), Columbia University (US), University of Sheffield (GB)
Bill and Melinda Gates Foundation, NHLBI Division of Intramural Research
Openalex Percentile: Top 27%
HIV/AIDS Research and Interventions
0.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.